Technology | November 02, 2011

Barnes Jewish Hospital Receives World’s First Superconducting Synchrocyclotron for Proton Therapy

November 2, 2011 — Mevion Medical Systems announced it has delivered the world's first superconducting synchrocyclotron to the S. Lee Kling Center for Proton Therapy at the Siteman Cancer Center at Barnes Jewish Hospital and Washington University School of Medicine in St. Louis, Mo. This inaugural shipment marks the last phase of the manufacturing of the first Mevion S250 proton accelerator module. The synchrocyclotron was delivered after a 1,200 mile, four-day trip from Mevion's headquarters in Littleton, Mass. to St. Louis.

Powered by a TriNiobium Core, the high-energy proton source of the Mevion S250 will preserve all of the benefits of conventional proton treatment systems while removing the obstacles of size, cost and complexity that have limited its wide adoption.

The system combines a patented, gantry-mounted proton source with a highly integrated, image-based workflow and robotic patient positioning. Similar to traditional radiation therapy systems in terms of footprint, workflow, and throughput, the device will easily integrate within existing radiation therapy departments.

"Barnes Jewish Hospital prides itself in providing the most advanced technologies to its patients. We are delighted to add this latest development in radiation therapy to our cancer-fighting arsenal," says Jeff Bradley, M.D., director of the S. Lee Kling Center for Proton Therapy at Siteman Cancer Center.

System installation is to be completed early next year. Two additional facilities are also in the midst of installation; Robert Wood Johnson University Hospital in New Brunswick, N.J. and Oklahoma University in Oklahoma City, Okla. Both of these installations are also to be completed in 2012.

For more information: www.mevion.com

Related Content

DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
Overlay Init